Opinion|Videos|August 6, 2024
Ideal Goals for Biosimilar Utilization
The panel discusses ideal goals for biosimilar utilization.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What are the ideal goals for biosimilar utilization?
- Similar to small molecule brands and generics: does the reference product go away and biosimilars have the great majority of utilization?
- Or does reference product stay on the market with pricing concessions?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Eplontersen Misses Primary End Point in Phase 3 ATTR-CM Cardiovascular Outcomes Trial
4
Contextualizing Golcadomide's Efficacy Signal in the RRFL Landscape
5